Barclays PLC (NYSE:BCS)
$ 13.4006 -0.0494 (-0.37%) Market Cap: 48.42 Bil Enterprise Value: -94.08 Bil PE Ratio: 9.12 PB Ratio: 0.54 GF Score: 68/100

Nestle SA Fireside Chat with Barclays PLC Transcript

May 05, 2023 / NTS GMT
Release Date Price: $7.82 (+4.69%)
Warren Ackerman
Barclays Investment Bank - Analyst

Hello, everybody. I'm Warren Ackerman, Head of Consumer Staples at Barclays. I'm delighted to be in Vevey, Nestlé's global headquarters with Mark Schneider, CEO of Nestlé. We've got a fireside chat. We've got an action-packed agenda. Thank you, Mark.

We're going to try to get through as many questions as possible, so let's get cracking.

Questions & Answers

Warren Ackerman
Barclays Investment Bank - Analyst

So Mark, first question. Welcome. Can we just maybe start on M&A? Because since you've been CEO, you've rotated 20% of the portfolio and create a lot of value. However, there's been a few, maybe missteps recently, particularly Aimmune where you -- there's a write down happening.

What lessons have you learned from that? What are the potential outcomes from the Aimmune strategic review and how are you thinking about the bioscience's strategy within health sciences? And the reason why I asked this is because there is a little bit of concern about Ceres. Could it go the same way

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot